New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
Francesco Bennardo, Caterina Buffone, Amerigo Giudice
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)InterleukinInternal medicineVirologyCytokineRheumatoid arthritisDiseaseInfectious disease (medical specialty)OutbreakBone health and treatmentsDermatological and COVID-19 studiesBone and Joint Diseases